Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects

Author： Browning M. Larson C. Strauss A. Marsden D.

Publisher： Springer Publishing Company

ISSN： 0141-8955

Source： Journal of Inherited Metabolic Disease, Vol.28, Iss.4, 2005-06, pp. : 545-550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening

By Spiekerkoetter Ute

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 5, 2010-10 ,pp. : 527-532

Springer Publishing Company

Access to resources Recommend Favorite

Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting

By Lindner Martin Hoffmann Georg Matern Dietrich

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 5, 2010-10 ,pp. : 521-526

Springer Publishing Company

Access to resources Recommend Favorite

Long-Chain Polyunsaturated Fatty Acids

Neonatology, Vol. 74, Iss. 2, 1998-07 ,pp. : 106-120

Karger

Access to resources Recommend Favorite

Very long-chain acyl-CoA dehydrogenase deficiency: The effects of accidental fat loading in a patient detected through newborn screening

By Ficicioglu C. Hussa C.

Journal of Inherited Metabolic Disease, Vol. 32, Iss. 1, 2009-12 ,pp. : 187-190

Springer Publishing Company

Access to resources Recommend Favorite

Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation

By Engelen Marc

Journal of Inherited Metabolic Disease, Vol. 35, Iss. 6, 2012-11 ,pp. : 1137-1145

Springer Publishing Company

Access to resources Recommend Favorite